At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Quality Control of CE-Certified Phonak Hearing Aids - 2020_43
In Brief
A clinical study evaluating Feature for noise reduction (on) and Feature for noise reduction (off) for Hearing Loss. Completed, enrolled 10 participants across 1 site.
Detailed Summary
Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features, functions and wearing comfort. This will be a clinical investigation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).
Study Details
Timeline
Interventions
The noise reduction feature shall support the hearing aid user in noisy situations and shall reduce the listening effort.
To show the advantage of the noise reduction feature there is a comparison without the feature necessary.